Multiple comparisons of three different sources of biomaterials in the application of tumor tissue engineering in vitro and in vivo

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

M. William Audeh, James Carmichael, Richard T. Penson et al. · The Lancet · 2010 · 2.3K citations

Medicine, Gynecology, Oncology +16

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Andrew Tutt, Mark E. Robson, Judy E. Garber et al. · The Lancet · 2010 · 1.6K citations

Medicine, Oncology, Pharmacotherapy +13

Large-scale production, properties and commercial applications of polylactic acid polymers

James Lunt · Polymer Degradation and Stability · 1998 · 1.3K citations

Natural Sciences, Materials Engineering, Materials Science +16

The morphologies of breast cancer cell lines in three-dimensional assays correlate with \ntheir profiles of gene expression

Paraic A. Kenny, Genee Y. Lee, Connie A. Myers et al. · eScholarship (California Digital Library) · 2008 · 1.1K citations

Life Sciences, Cell Biology, Oncology +12

In vitro characterization of chitosan–gelatin scaffolds for tissue engineering

Yan Huang, Stella Onyeri, Mbonda Siewe et al. · Biomaterials · 2005 · 653 citations

Engineering, Bioengineering, Biomedical Engineering +16